INVA

Q: What is the price of Innoviva (INVA) today?

The price of Innoviva (INVA) today is R$ 108,02, with a variation of 5.23% compared to the last year. The price of Innoviva (INVA) started the year trading around R$ 94,04 and today it is at R$ 108,02. Follow the real-time price chart, the historical price of Innoviva (INVA), and stock data from Ibovespa and international markets.

Q: When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not distribute dividends in the last year.

Q: Innoviva (INVA) is it worth it?

Currently, Innoviva (INVA) is priced at R$ 108,02, with a P/E of 32,85%, representing a deviation of 19,07% from its historical average P/E. In the last year, the stock showed a variation of 5.23% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 5,23%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Innoviva (INVA)?

Investing in shares of Innoviva (INVA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Innoviva (INVA) yield today?

The yield of Innoviva (INVA) was 6,46% in the last month, 5,23% in the last year and 70,93% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Innoviva (INVA) today, the total investment would be based on the current price of R$ 108,02.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 11.367,01In 5 years: R$ 18.463,96In 10 years: 15.857,42It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Innoviva Inc.

Price

US$ 19,93

variation (12m)

5,23%

p/l

32,85

p/vp

1,78

DIVIDEND YIELD

0,00%

quote INVA

BVMF

INVA

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of INVA

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

6,46%

3 months

4,24%

1 year

5,23%

2 years

51,79%

5 years

70,93%

10 years

46,80%

real profitability

profitability minus inflation.

1 month

6,46%

3 months

3,72%

1 year

-0,02%

2 years

38,36%

5 years

24,90%

10 years

-12,97%

Indicators INVA

check out the fundamentals of Innoviva shares

P/L

32,85

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

3,43

Sector: -3,77 Industry: -3,77

P/VP

1,78

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

2,90%

Sector: -63,50% Industry: -63,50%

ROE

5,41%

Sector: -67,23% Industry: -67,23%

ROIC

19,45%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

10,44%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

90,12%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

47,69%

Sector: -43,21% Industry: -43,21%

P/EBITDA

11,38

Sector: -3,13 Industry: -3,13

P/EBIT

14,85

Sector: -3,41 Industry: -3,41

P/ASSETS

0,95

Sector: 1,29 Industry: 1,29

VPA

11,35

Sector: 1,80 Industry: 1,80

LPA

0,61

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,54

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

1,91%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-29,66%

Sector: - Industry: -

FAIR PRICE OF Innoviva ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 19,93

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-37,38%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

INVA indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of INVA with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history INVA dividend history

Current DY: 0,00%

5-year average DY: 0,00%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	10/09/2015	30/09/2015	0,25000000
Dividends	12/06/2015	30/06/2015	0,25000000
Dividends	12/03/2015	31/03/2015	0,25000000
Dividends	25/11/2014	23/12/2014	0,25000000
Dividends	28/08/2014	18/09/2014	0,25000000

ABOUT THE COMPANY Innoviva

Innoviva Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

29 years

Foundation: 1996

2004

Year of debut on the stock exchange - 21 years

5

Employees

The Company Innoviva Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,27 Billion, having a net worth of $ 714,82 Milhões.

With a total of 5 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 370,23 Milhões, which generated a profit in the amount of $ 38,65 Milhões.

As for its main indicators, the Company has a P/E ratio of 32,85, a P/B ratio of 1,78 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker INVA.

Market value

US$ 1,27 Billion

Net worth

US$ 714,82 Milhões

US$ 714.820.000,00

Assets

US$ 1,33 Billion

US$ 1.333.570.000,00

Total Number of Shares

63,00 Milhões

63.000.000

Average Daily Trading Volume

US$ 907,25 Thousand

US$ 907.246,82

Sector

Cuidados de saúde

Industry

Biotecnologia

INVA

INVA revenue and profits

INVA results

DRAG THE FRAME TO SEE MORE DATA

INVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Innoviva (INVA) today?

The price of Innoviva (INVA) today is R$ 108,02, with a variation of 5.23% compared to the last year. The price of Innoviva (INVA) started the year trading around R$ 94,04 and today it is at R$ 108,02. Follow the real-time price chart, the historical price of Innoviva (INVA), and stock data from Ibovespa and international markets.

When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not distribute dividends in the last year.

Innoviva (INVA) is it worth it?

Currently, Innoviva (INVA) is priced at R$ 108,02, with a P/E of 32,85%, representing a deviation of 19,07% from its historical average P/E. In the last year, the stock showed a variation of 5.23% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 5,23%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Innoviva (INVA)?

Investing in shares of Innoviva (INVA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Innoviva (INVA) yield today?

The yield of Innoviva (INVA) was 6,46% in the last month, 5,23% in the last year and 70,93% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Innoviva (INVA) today, the total investment would be based on the current price of R$ 108,02.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 11.367,01
In 5 years: R$ 18.463,96
In 10 years: 15.857,42

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INVA

Innoviva Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of INVA

check out the fundamentals of Innoviva shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

type

date with

payment date

value

ABOUT THE COMPANY Innoviva

Innoviva Inc.

Estados Unidos

29 years

2004

5

PROFIT X PRICE INVA

INVA results

INVA cash flow

evolution of assets - INVA

INVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80